Emma Leishman
- Pharmacology top 1%
- Cellular and Molecular Neuroscience top 5%
- Molecular Biology
- Cognitive Neuroscience top 5%
- Physiology top 10%
- Co-authors
- Heather B. BradshawKen MackieAlex StraikerSally MillerJim Wager‐MillerMichelle MurphySerge LuquetSudhansu K. Dey
- Topics
- Cannabis and Cannabinoid Research (33 papers)Neuroscience and Neuropharmacology Research (10 papers)Sleep and Wakefulness Research (9 papers)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Emma Leishman
51 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 100
- Pharmacology 887
- Cellular and Molecular Neuroscience 456
- Molecular Biology 303
- Cognitive Neuroscience 276
- Physiology 254
Countries citing papers authored by Emma Leishman
This map shows the geographic impact of Emma Leishman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Leishman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Leishman more than expected).
Fields of papers citing papers by Emma Leishman
This network shows the impact of papers produced by Emma Leishman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Leishman. The network helps show where Emma Leishman may publish in the future.
Co-authorship network of co-authors of Emma Leishman
This figure shows the co-authorship network connecting the top 25 collaborators of Emma Leishman. A scholar is included among the top collaborators of Emma Leishman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma Leishman. Emma Leishman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 6 | |
| 3 | 12 | |
| 4 | 21 | |
| 5 | 14 | |
| 6 | 19 | |
| 7 | 40 | |
| 8 | 36 | |
| 9 | 18 | |
| 10 | 19 | |
| 11 | 7 | |
| 12 | 93 | |
| 13 | 29 | |
| 14 | 8 | |
| 15 | 34 | |
| 16 | 15 | |
| 17 | 32 | |
| 18 | 91 | |
| 19 | 86 | |
| 20 | 71 |
About Emma Leishman
Emma Leishman is a scholar working on Pharmacology, Toxicology and Endocrine and Autonomic Systems, having authored 51 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cannabis and Cannabinoid Research (33 papers), Neuroscience and Neuropharmacology Research (10 papers) and Sleep and Wakefulness Research (9 papers). The work is most often cited by research in Pharmacology (887 citations), Toxicology (115 citations) and Sensory Systems (151 citations). Emma Leishman has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Heather B. Bradshaw, Ken Mackie, Alex Straiker, Sally Miller, Jim Wager‐Miller, Michelle Murphy, Serge Luquet, Sudhansu K. Dey, Hirofumi Haraguchi and Catherine Bagot. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.